Cue Biopharma, Inc. - Special Call Transcript
Good afternoon, and welcome to Cue Biopharma's Quarterly Investor and Analyst Update Conference Call. (Operator Instructions) I will now turn the call over to John Woolford.
Good afternoon. This is John Woolford from Westwicke. Thank you for joining us on today's investor and analyst update call.
Joining me on the call today are Dan Passeri, Cue Biopharma's President and CEO; Dr. Anish Suri, Chief Scientific Officer; Dr. Ken Pienta, Acting Chief Medical Officer; and Kerri-Ann Millar, VP of Finance and Principal Accounting and Finance Officer. Also joining us on the call is Bethany Mancilla, our Chief Business Officer, who will be available for the Q&A section of the call. I want to note that a slide deck for today's call is available through the webcast in the Investors section of our website, www.cuebio.com.
Before we begin, I'd like to remind you that during today's call, the company will be making forward-looking statements.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
